Somatostatin agonists for treatment of acromegaly

Molecular and Cellular Endocrinology
Anat Ben-Shlomo, Shlomo Melmed

Abstract

The discovery of somatotropin-release inhibitory factor (SRIF) in hypothalamic extract in 1970 led to the synthesis of the first somatostatin analog octreotide, discovery of five somatostatin receptor subtypes, and development of additional somatostatin receptor ligands (SRL) as pharmacotherapy for acromegaly and other neuroendocrine tumors. Long-acting formulations of SRL (octreotide LAR Depot, lanreotide SR and lanreotide autogel) assure improved patient compliance with weekly up to monthly injections, and are commonly used as primary or adjuvant treatment of acromegaly. We review SRL currently available, emphasizing long-acting compounds and their efficacy in controlling acromegaly. Disease control is evaluated by biochemical markers, tumor shrinkage, and disease-symptom improvement balanced against drug-related side effects.

References

Dec 1, 1986·Annals of Internal Medicine·L B BarnardI M Jackson
Jul 1, 1994·European Journal of Endocrinology·J MarekF Thomas
Jul 1, 1994·Clinical Endocrinology·C RajasooryaH K Ibbertson
Oct 1, 1996·Clinical Endocrinology·M al-MaskariP Kendall-Taylor
Jan 1, 1997·The Journal of Clinical Endocrinology and Metabolism·P CaronP Jaquet
Jan 1, 1997·The Journal of Clinical Endocrinology and Metabolism·A K FløgstadJ Jervell
Aug 6, 1999·Frontiers in Neuroendocrinology·Y C Patel
Sep 1, 1999·Clinical Endocrinology·H E TurnerJ A Wass
Sep 4, 1999·European Journal of Endocrinology·R CozziG Oppizzi
Sep 22, 2000·The Journal of Clinical Endocrinology and Metabolism·A ColaoG Lombardi
Nov 18, 2000·European Journal of Endocrinology·J A VerhelstG Pagani
Feb 13, 2001·Diabetes Research and Clinical Practice·D BruttomessoS Del Prato
Jan 15, 2002·The Journal of Clinical Endocrinology and Metabolism·Ph CaronW Zgliczynski
Mar 12, 2002·Metabolism: Clinical and Experimental·Maria Rosaria AmbrosioEttore C degli Uberti
Jul 11, 2002·The Journal of Clinical Endocrinology and Metabolism·Pamela U Freda
Jul 11, 2002·The Journal of Clinical Endocrinology and Metabolism·Annamaria ColaoGaetano Lombardi
Jul 12, 2002·Journal of Endocrinological Investigation·C RonchiM Arosio
Sep 6, 2002·The Journal of Clinical Endocrinology and Metabolism·John AyukMichael C Sheppard
Jan 30, 2003·Journal of Endocrinological Investigation·G LombardiUNKNOWN Multicenter Italian Study Group on Lanreotide
Mar 12, 2003·The Journal of Clinical Endocrinology and Metabolism·Anat Ben-Shlomo, Shlomo Melmed
Mar 19, 2003·Clinical Endocrinology·Tomás LucasUNKNOWN Spanish Multicentre Lanreotide Study Group on Acromegaly
Jul 5, 2003·The Journal of Clinical Endocrinology and Metabolism·Renato CozziAlberto M Pedroncelli
Sep 27, 2003·Clinical Endocrinology·Roberto BaldelliGuido Tamburrano
Nov 7, 2003·The Journal of Clinical Endocrinology and Metabolism·Roberto AttanasioRenato Cozzi
Dec 5, 2003·Nature Reviews. Drug Discovery·Gisbert WeckbeckerChristian Bruns
Feb 7, 2004·The Journal of Clinical Endocrinology and Metabolism·Ian M HoldawayGreg D Gamble
Feb 11, 2004·Endocrine Reviews·Annamaria ColaoGaetano Lombardi
Mar 25, 2005·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·B GuttJ Schopohl
Apr 14, 2005·The Journal of Clinical Endocrinology and Metabolism·Shlomo MelmedAriel Barkan
May 12, 2005·The Journal of Clinical Endocrinology and Metabolism·Pamela U FredaDaniel Rabinowitz
Aug 3, 2005·Clinical Endocrinology·Raquel S JalladMarcello D Bronstein
Sep 13, 2005·Metabolism: Clinical and Experimental·Joseph M CendrosRossend Obach
Nov 2, 2005·Expert Opinion on Pharmacotherapy·Nienke R BiermaszFerdinand Roelfsema
Dec 3, 2005·European Journal of Endocrinology·S MelmedA Giustina
Jan 25, 2006·Clinical Endocrinology·Philippe CaronJean Marc Kuhn

❮ Previous
Next ❯

Citations

Jun 27, 2012·Nature Reviews. Endocrinology·Antônio Ribeiro-Oliveira, Ariel Barkan
Oct 12, 2010·Journal of Endocrinological Investigation·O Celik, P Kadioglu
Mar 22, 2014·Journal of Molecular Endocrinology·Daniel Cuevas-Ramos, Maria Fleseriu
Dec 5, 2008·Expert Opinion on Investigational Drugs·Jens BollerslevJens P Berg
Jan 10, 2014·Expert Opinion on Emerging Drugs·Sylvère Störmann, Jochen Schopohl
Aug 28, 2012·European Journal of Internal Medicine·Cecilia MerciecaJosanne Vassallo
Feb 13, 2010·Trends in Endocrinology and Metabolism : TEM·Anat Ben-Shlomo, Shlomo Melmed
Feb 9, 2008·Molecular and Cellular Endocrinology·Raul M LuqueRhonda D Kineman
Jan 30, 2008·Endocrinology and Metabolism Clinics of North America·Anat Ben-Shlomo, Shlomo Melmed
Mar 12, 2016·Gastroenterología y hepatología·María Del Rosario CalderónFrancisco García Campos
Jul 6, 2011·Analytical Biochemistry·Nobuo FukudaAkihiko Kondo
Jul 3, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Maria FleseriuUNKNOWN AACE Neuroendocrine and Pituitary Scientific Committee
Mar 23, 2011·Biochimica Et Biophysica Acta·Geetanjali KharmateUjendra Kumar
Dec 18, 2014·Endocrine-related Cancer·Misu LeeNatalia S Pellegata
May 15, 2008·The Journal of Clinical Endocrinology and Metabolism·Robert D Murray, Shlomo Melmed
Aug 9, 2018·Endocrine, Metabolic & Immune Disorders Drug Targets·Franca DicuonzoVicenzo Triggiani
Oct 29, 2018·Hormones : International Journal of Endocrinology and Metabolism·Metaxia TampourlouStylianos Tsagarakis
Jul 15, 2015·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Frank ScherbarthPerry Barrett
Jun 24, 2011·The Journal of Clinical Endocrinology and Metabolism·Dalit Modan-MosesHeddy Landau
Aug 25, 2020·Acta Crystallographica Section B, Structural Science, Crystal Engineering and Materials·Stavroula FiliIrene Margiolaki
Feb 9, 2017·Pituitary·Monica R GadelhaDiego Ferone
Sep 1, 2012·Expert Review of Endocrinology & Metabolism·Kelley J MoloneyMarc R Mayberg
May 20, 2015·The Journal of Veterinary Medical Science·Kosei SakaiToshifumi Oyamada
Dec 26, 2018·Expert Opinion on Drug Safety·Amandeep GodaraMuhammad Wasif Saif
Mar 23, 2018·Frontiers in Endocrinology·Rosa Maria Paragliola, Roberto Salvatori

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.